Limbal stem cell transplantation for primary pterygium
Author:
Fund Project:

National Natural Science Foundation of China(No.81770934); Hospital Level Fund of Central Hospital of Minhang District(No.2017MHLC05)

  • Article
  • | |
  • Metrics
  • |
  • Reference [22]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    AIM: To evaluate the safety and efficacy of limbal conjunctival autograft transplantation for treating primary pterygium over a period of 3y.

    METHODS: Prospective observational consecutive case series. In this study, 264 eyes of 264 patients(142 males and 122 females)with nasal primary pterygium were treated using the technique of limbal conjunctival autograft. The mean ages of the patients were 54.22±15.24a. After excision of the pterygium patients were followed up on 1, 3, 7d and at 1, 3, 6, 9, 12 and 36mo. Recurrence of pterygium, complications, operation time and corneal epithelialization time were evaluated.

    RESULTS: The average surgery time was 25.7±2.6min. With a minimum 3-year of follow-up, postoperative corneal epithelialization was completed in 3.85±0.72d. Complications were observed in 14 cases. Vision-threating complications such as iritis, scleral thinning symblepharon or ulceration were not detected in the study. 5 eyes with graft edema, 3 eyes with granuloma formation and 6 cases with a subconjunctival hematoma in the nasal conjunctiva. By the end of 3-year follow-up, recurrence was detected in 11 cases. The recurrence rate was 4.17%, and the onset of recurrence was 3mo, the average recurrence time was 8mo.

    CONCLUSION: There were no severe complications and few recurrences when limbal conjunctival autograft transplantation was performed after long-term follow-up, we suggest that limbal conjunctival autograft transplantation is a safe and effective technique in primary pterygium. We also recommend that 12-month follow-up is optimal on primary pterygium surgery.

    Reference
    1 Jaworski CJ, Aryankalayil-John M, Campos MM, Fariss RN, Rowsey J, Agarwalla N, Reid TW, Dushku N, Cox CA, Carper D, Wistow G. Expression analysis of human pterygium shows a predominance of conjunctival and limbal markers and genes associated with cell migration. Mol Vis 2009; 15:2421-2434
    2 Young AL, Cao D, Chu WK, Ng TK, Yip YWY, Jhanji V, Pang CP. The evolving story of pterygium. Cornea 2018; 37(Suppl 1):S55-S57
    3 Ozturk BT, Yildirim MS, Zamani A, Bozkurt B. K-ras oncogene mutation in pterygium. Eye 2017; 31(3):491-498
    4 di Girolamo N. Association of human papilloma virus with pterygia and ocular-surface squamous neoplasia. Eye 2012; 26(2):202-211
    5 Lan W, Petznick A, Heryati S, Rifada M, Tong L. Nuclear Factor-kappa B: central regulator in ocular surface inflammation and diseases. Ocul Surf 2012; 10(3):137-148
    6 Park CY, Choi JS, Lee SJ, Hwang SW, Kim EJ, Chuck RS. Cyclooxygenase-2-expressing macrophages in human pterygium co-express vascular endothelial growth factor. Mol Vis 2011; 17:3468-3480
    7 Kaufman SC, Jacobs DS, Lee WB, Deng SX, Rosenblatt MI, Shtein RM. Options and adjuvants in surgery for pterygium: a report by the American Academy of Ophthalmology. Ophthalmology 2013; 120(1):201-208
    8 Marsit N, Gafud N, Kafou I, Mabrouk A, Alatiweel A, Abdalla S, Sheghewi L. Safety and efficacy of human amniotic membrane in primary pterygium surgery. Cell Tissue Bank 2016; 17(3):407-412
    9 Rose L, Byrd JM, Qaseem Y. Subtenon injections of ranibizumab arrest growth in early recurrent pterygium. Eye Contact Lens 2017; 43(6):399-405
    10 Chen RX, Huang GF, Liu S, Ma WF, Yin XF, Zhou SY. Limbal conjunctival versus amniotic membrane in the intraoperative application of mitomycin C for recurrent pterygium: a randomized controlled trial. Albrecht Von Graefes Arch Fur Klinische Und Exp Ophthalmol 2017; 255(2):375-385
    11 Hwang S, Choi S. A comparative study of topical mitomycin C, cyclosporine, and bevacizumab after primary pterygium surgery. Korean J Ophthalmol 2015; 29(6):375-381
    12 Petrayevsky AV, Trishkin KS. Surgical treatment of pterygium. Vestn Ophthalmol 2018; 134(1):85-88
    13 Clearfield E, Muthappan V, Wang X, Kuo IC. Conjunctival autograft for pterygium. Cochrane Database Syst Rev 2016; 2:CD011349
    14 Koranyi G, Artzén D, Seregard S, Kopp ED. Intraoperative mitomycin C versus autologous conjunctival autograft in surgery of primary pterygium with four-year follow-up. Acta Ophthalmol 2012; 90(3):266-270
    15 Donepudi GD, Ramesh S, Govindarajulu M, Dhanasekaran M, Moore T, Ganekal S, Hiremath CS. Early postoperative outcomes of pterygium surgery: sutures versus autogenous serum in-situ fixation of limbal conjunctival autograft. Life Sciences 2019; 221:93-98
    16 Mednick Z, Boutin T, Einan-Lifshitz A, Sorkin N, Slomovic A. Simple limbal epithelial transplantation for recurrent pterygium: a case series. Am J Ophthalmol Case Rep 2018; 12:5-8
    17 Ozer A, Yildirim N, Erol N, Yurdakul S. Long-term results of bare sclera, limbal-conjunctival autograft and amniotic membrane graft techniques in primary pterygium excisions. Ophthalmologica 2009; 223(4):269-273
    18 Detorakis ET, Spandidos DA. Pathogenetic mechanisms and treatment options for ophthalmic pterygium: trends and perspectives(Review). Int J Mol Med 2009; 23(4):439-447
    19 Nuzzi R, Tridico F. How to minimize pterygium recurrence rates: clinical perspectives. Clin Ophthalmol 2018; 12:2347-2362
    20 Soliman Mahdy MA, Bhatia J. Treatment of primary pterygium: role of limbal stem cells and conjunctival autograft transplantation. Oman J Ophthalmol 2009; 2(1):23-26
    21 Malik KP, Goel R, Gutpa A, Gupta SK, Kamal S, Mallik VK, Singh S. Efficacy of sutureless and glue free limbal conjunctival autograft for primary pterygium surgery. Nepal J Ophthalmol 2012; 4(2):230-235
    22 Masters JS, Harris DJ Jr. Low recurrence rate of pterygium after excision with conjunctival limbal autograft: a retrospective study with long-term follow-up. Cornea 2015; 34(12):1569-1572
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Wang TY, Gu YF, Yang M,/et al.Limbal stem cell transplantation for primary pterygium. Guoji Yanke Zazhi(Int Eye Sci) 2020;20(9):1473-1476,DOI:10.3980/j. issn.1672-5123.2020.9.01

Copy
Share
Article Metrics
  • Abstract:1100
  • PDF: 1305
  • HTML: 0
  • Cited by: 0
Publication History
  • Received:June 05,2019
  • Revised:June 15,2020
  • Online: August 19,2020